Therapy Analysis & Statistics, July 2014

Talk to Amrita

+1 718 303 2019

Search inside this page

All regions

You might be interested in: therapeutics, biotherapeutics, cancer therapeutics, more »

1-30 of about 4 800 reports

Purchase Reports From Reputable Market Research Publishers

Therapeutics for Women%s Health: Technologies and Global Markets

Therapeutics for Women%s Health: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • May 2014
  • by BCC Research

Use this report to: - Learn about the main women's health disorders and relevant disease prevalence population. - Identify the impact of demographic, economic, and other factors that will drive future ...

  • Industries : Therapy
  • Countries : World
OpportunityAnalyzer: Gout - Opportunity Analysis and Forecast to 2018

OpportunityAnalyzer: Gout - Opportunity Analysis and Forecast to 2018

  • $ 5 995
  • Industry report
  • April 2014
  • by Global Data

OpportunityAnalyzer: Gout - Opportunity Analysis and Forecast to 2018 Summary GlobalData estimates the 2013 sales for gout at approximately $989m across the 6MM covered in this report. The acute gout segment ...

  • Industries : Therapy
  • Countries : United States
Chronic Lymphocytic Leukaemia: KOL Insight

Chronic Lymphocytic Leukaemia: KOL Insight

  • $ 5 369
  • Industry report
  • May 2014
  • by Firstword Pharma

Chronic lymphocytic leukaemia (CLL) is the most common of the leukaemias, but until recently it has been underserved in terms of effective therapeutic options. However, a revolution in personalised and ...

  • Industries : Therapy
A Product and Pipeline Analysis of the Global Diabetes Therapeutics Market

A Product and Pipeline Analysis of the Global Diabetes Therapeutics Market

  • $ 5 000
  • Industry report
  • April 2014
  • by Frost & Sullivan

The marketed and development product landscape for diabetes therapeutics is becoming crowded with multiple products with little differentiation. However, there is still ample room for growth through the ...

  • Industries : Therapy
  • Countries : World
Recent Biotech Funding, Deals and Partnerships

Recent Biotech Funding, Deals and Partnerships

  • $ 4 500
  • Industry report
  • May 2014
  • by Kalorama Information

Nearly one out of every 8 dollars invested in companies are invested in biotech. Biotech investment has increased significantly in the past few years, and 2013 saw a notable spike. In the last few years, ...

  • Industries : Therapy
  • Countries : United States
MarketVIEW: allergic immunotherapies

MarketVIEW: allergic immunotherapies

  • $ 4 495
  • Industry report
  • July 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Allergy or Allergic rhinitis is caused by sensitivity to a number of environmental factors including grass, tree and weed pollens, house dust mite and cat dander. Prevalence in adults can range from 17 ...

  • Industries : Therapy
  • Countries : Japan, World, Europe, France, Netherlands, United States, Spain, Italy, Germany, United Kingdom, Denmark
Health Care Markets in China

Health Care Markets in China

  • $ 4 000
  • Industry report
  • May 2014
  • by Asia Market Information & Development Company

China's demand for Health Care has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment ...

  • Industries : Therapy
  • Countries : China
Inhaled COPD Therapeutics Market

Inhaled COPD Therapeutics Market

  • $ 3 850
  • Industry report
  • June 2014
  • by Greystone Research Associates

COPD is not one but a family of conditions, each with its own etiology and treatment challenges. Chronic bronchitis is the inflammation and eventual scarring of the lining of the bronchial tubes. Oral ...

  • Industries : Therapy
Inhaled Asthma Therapeutics Market

Inhaled Asthma Therapeutics Market

  • $ 3 850
  • Industry report
  • June 2014
  • by Greystone Research Associates

Asthma continues to be a health segment with significant incidence and morbidity. There has been significant interest directed toward the development easier-to-use inhalers, primarily because a large segment ...

  • Industries : Therapy
Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market

  • $ 3 500
  • Industry report
  • July 2014
  • by GBI Research

Critical Care Therapeutics in Major Developed Markets to 2020 - New and Late-Stage Four-Factor PCCs and Recombinant Products to Drive Market Summary GBI Research, the leading business intelligence provider, ...

  • Industries : Therapy
  • Countries : France, Canada, Japan, Spain, Italy, Germany, United States, Europe, United Kingdom, World
Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs Summary GBI Research, the leading business intelligence ...

  • Industries : Therapy
  • Countries : World
Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries

Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

Antihypertensive Therapeutics in Major Developed Markets to 2020 - Increased Uptake of Combination Therapies to Offset Effects of Key Patent Expiries Summary GBI Research, the leading business intelligence ...

  • Industries : Therapy
  • Countries : World
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2019 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Summary GBI Research, a leading business ...

  • Industries : Therapy
  • Countries : World, Germany, Japan, United States, Europe, North America, Canada, Spain, Italy, France, United Kingdom
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020

Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020

  • $ 3 500
  • Industry report
  • June 2014
  • by GBI Research

Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany The Glioblastoma Multiforme (GBM) treatment market is forecast to grow rapidly from $301 million in 2013 to $623 ...

  • Industries : Therapy
  • Countries : World
Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies

Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies

  • $ 3 500
  • Industry report
  • May 2014
  • by GBI Research

Ovarian Cancer Therapeutics in Major Developed Markets to 2020 - Late-Stage Pipeline Focuses on Improved Progression Free-Surival and Targeted Therapies Summary GBI Research, has released the pharma report ...

  • Industries : Therapy
  • Countries : World
Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options

Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options

  • $ 3 500
  • Industry report
  • May 2014
  • by GBI Research

Breast Cancer Therapeutics in Asia-Pacific Markets to 2020 - Novel HER-2 Positive Therapies Provide Diversified Treatment Options Summary GBI Research, the leading business intelligence provider, has released ...

  • Industries : Therapy
  • Countries : World, Australia, Japan, China, India
Companion Diagnostics in Personalized Medicine and Cancer Therapy

Companion Diagnostics in Personalized Medicine and Cancer Therapy

  • $ 3 400
  • Industry report
  • June 2014
  • by TriMark Publications

Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy. This linkage could be important in the therapeutic ...

  • Industries : Therapy
Inhaled CNS Therapeutics Market

Inhaled CNS Therapeutics Market

  • $ 2 850
  • Industry report
  • June 2014
  • by Greystone Research Associates

Neurological disorders are highly prevalent worldwide. And while mental and neurological disorders are responsible for about one per cent of deaths, they account for almost 11 per cent of disease burden ...

  • Industries : Therapy
Global Hormone Replacement Therapy Market 2014-2018

Global Hormone Replacement Therapy Market 2014-2018

  • $ 2 500
  • Industry report
  • July 2014
  • by Infiniti Research Limited

About Hormone Replacement Therapy Hormone replacement therapy, also known as hormone therapy, is a means of replacing hormones that are no longer being produced by the body. This type of therapy is usually ...

  • Industries : Therapy
  • Countries : World
Inflammation - Pipeline Review, H1 2014

Inflammation - Pipeline Review, H1 2014

  • $ 2 500
  • Company report
  • June 2014
  • by Global Markets Direct

Inflammation - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Inflammation - Pipeline Review, H1 2014', provides an overview of the Inflammation's therapeutic pipeline. This report provides ...

  • Industries : Therapy
Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018

Global Non-Hodgkin Lymphoma Therapeutics Market 2014-2018

  • $ 2 500
  • Industry report
  • June 2014
  • by Infiniti Research Limited

About Non-Hodgkin Lymphoma (NHL) and its Diagnostic Procedures Non-Hodgkin lymphoma (NHL) is a condition of the human body leading to the production of abnormal lymphocytes. In normal circumstances, the ...

  • Industries : Therapy
  • Countries : World
Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2014

Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • June 2014
  • by Global Data

Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Diabetic Neuropathic Pain Global Clinical Trials Review, H1, 2014" provides data on the ...

  • Industries : Therapy
  • Countries : World
Neuropathic Pain Global Clinical Trials Review, H1, 2014

Neuropathic Pain Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • June 2014
  • by Global Data

Neuropathic Pain Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Neuropathic Pain Global Clinical Trials Review, H1, 2014" provides data on the Neuropathic Pain clinical ...

  • Industries : Therapy
  • Countries : World
Global Choroidal Neovascularization (CNV) Market 2014-2018.pdf

Global Choroidal Neovascularization (CNV) Market 2014-2018.pdf

  • $ 2 500
  • Industry report
  • May 2014
  • by Infiniti Research Limited

About CNV CNV is defined as a process in which new blood vessels grow in the choroid through the bruch membrane, which is the innermost layer of the choroid, and attack the sub-retinal space. Even though ...

  • Industries : Therapy
  • Countries : World
Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014

Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • May 2014
  • by Global Data

Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Squamous Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014" provides ...

  • Industries : Therapy
  • Countries : World
Diffuse Diabetic Macular Edema Global Clinical Trials Review, H1, 2014

Diffuse Diabetic Macular Edema Global Clinical Trials Review, H1, 2014

  • $ 2 500
  • Industry report
  • May 2014
  • by Global Data

Diffuse Diabetic Macular Edema Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Diffuse Diabetic Macular Edema Global Clinical Trials Review, H1, 2014" provides data ...

  • Industries : Therapy
  • Countries : World
Protein Kinase Inhibitors Drug Pathway Analyzer 2014

Protein Kinase Inhibitors Drug Pathway Analyzer 2014

  • $ 2 999
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 963 protein kinase inhibitor drugs known to affect more than 250 specific intracellular signaling pathways ...

  • Industries : Therapy
 Diabetic Nephropathy Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Diabetic Nephropathy Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Diabetic Nephropathy- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs ...

  • Industries : Therapy
  • Countries : United States, World
 Hepatic Edema Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Hepatic Edema Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Hepatic Edema- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and ...

  • Industries : Therapy
  • Countries : United States, World
 Congenital Hypoplastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

Congenital Hypoplastic Anemia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

  • $ 2 000
  • Industry report
  • July 2014
  • by Delve Insight

SUMMARY DelveInsight's, “ Congenital Hypoplastic Anemia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline ...

  • Industries : Therapy
  • Countries : United States
About 700 reports

Download Unlimited Documents from Trusted Public Sources

General Medicine And Specialty Medicine Industry - Company Report, July 2014

  • Prostate Cancer Treatment: Unproven Proton Radiation Therapy Was...
  • July 2014
    4 pages
  • Radiation Thera...  

    Prostate Cancer  

  • United States  

View report >

About 100 Companies

Read our Company Profiles

Pfizer Inc.

United States

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

Johnson and Johnson

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.